CLOs on the Move

St Luke's Hospital

www.slhmarion.org

 
St Luke's Hospital is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Marion, KS. To find more information about St Luke's Hospital, please visit www.slhmarion.org
  • Number of Employees: 0-25
  • Annual Revenue: $50-100 Million

Executives

Name Title Contact Details

Similar Companies

BridgePoint Medical

BridgePoint Medical is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Faith Health Care

Faith Health Care is a licensed home health agency that provides exceptional quality home health care, multi-disease management, and transitional care services. They are Medicare and Medicaid certified and CHAP accredited.

Healthcare Prncipals Group

Healthcare Prncipals Group LLC is a Beaufort, SC-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Memorial Hospital

Memorial Hospital is a proud part of University of Colorado Health, recognized as a national leader in quality and research. At the local level, Memorial provides a comprehensive list of inpatient and outpatient services at two hospitals and multiple outpatient locations. Memorial provides state-of-the-art, compassionate care in fields such as cardiology, neurology and oncology.

Mela Sciences

At MELA Sciences, we design and develop innovative software-driven medical technologies for physician clinical use during the detection of skin cancers at the most curable and cost-effective stages. Our mission is to develop breakthrough medical technologies to improve skin cancer detection and achieve better outcomes for all. We envision a world in which our pioneering innovations will change the way patients think about skin cancer, while providing dermatologists and clinicians with new, effective, non-invasive tools for the earliest detection possible. MELA Sciences conducted the largest, positive prospective study ever done on the melanoma disease, and is the first and only medical technology company to receive both FDA Pre-Market Approval (PMA) for the U.S. and CE Marking certification for the European Union for a device of this nature. The company’s flagship product, MelaFind®, is intended to provide dermatologists with software-driven image analysis of clinically atypical pigmented skin lesions when they choose to obtain additional information to help decide whether to biopsy or not. The FDA has approved MELA Sciences’ MelaFind® Pre-Market Approval application for use in the United States and MELA Sciences has also been granted CE Mark approval for sale of MelaFind® in the European Union.